SBI Securities’s CureVac CVAC Stock Holding History

SBI Securities’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-458	Closed	-$2.07K	–	4056
2025 Q4	$2.07K	Hold	458	–	–	﹤0.01%	2365
2025 Q3	$2.47K	Sell	458 -505	-52%	-$2.73K	﹤0.01%	2344
2025 Q2	$5.23K	Sell	963 -15	-2%	-$59	﹤0.01%	1969
2025 Q1	$2.71K	Buy	978 +700	+252%	+$2.44K	﹤0.01%	2161
2024 Q4	$948	Buy	+278	New	+$802	﹤0.01%	2631

SBI Securities's CVAC Position: Q1 2026 in Review

SBI Securities sold out of CureVac (CVAC) in Q1 2026, closing a stake of 458 shares — an estimated $2.07K sold.

SBI Securities first reported a position in CVAC in Q4 2024 and held it in 5 quarters. The position peaked at $5.23K in Q2 2025. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

SBI Securities reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
SBI Securities sold 458 CureVac shares in Q1 2026, an estimated $2.07K.
SBI Securities first reported a position in CureVac in Q4 2024 and held it in 5 quarters.
SBI Securities's CureVac position peaked at $5.23K in Q2 2025.
0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.